These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31618280)

  • 1. Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA.
    Quintana-Bustamante O; Fañanas-Baquero S; Orman I; Torres R; Duchateau P; Poirot L; Gouble A; Bueren JA; Segovia JC
    PLoS One; 2019; 14(10):e0223775. PubMed ID: 31618280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency.
    Fañanas-Baquero S; Quintana-Bustamante O; Dever DP; Alberquilla O; Sanchez-Dominguez R; Camarena J; Ojeda-Perez I; Dessy-Rodriguez M; Turk R; Schubert MS; Lattanzi A; Xu L; Lopez-Lorenzo JL; Bianchi P; Bueren JA; Behlke MA; Porteus M; Segovia JC
    Mol Ther Methods Clin Dev; 2021 Sep; 22():237-248. PubMed ID: 34485608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme.
    Meza NW; Alonso-Ferrero ME; Navarro S; Quintana-Bustamante O; Valeri A; Garcia-Gomez M; Bueren JA; Bautista JM; Segovia JC
    Mol Ther; 2009 Dec; 17(12):2000-9. PubMed ID: 19755962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.
    Garate Z; Quintana-Bustamante O; Crane AM; Olivier E; Poirot L; Galetto R; Kosinski P; Hill C; Kung C; Agirre X; Orman I; Cerrato L; Alberquilla O; Rodriguez-Fornes F; Fusaki N; Garcia-Sanchez F; Maia TM; Ribeiro ML; Sevilla J; Prosper F; Jin S; Mountford J; Guenechea G; Gouble A; Bueren JA; Davis BR; Segovia JC
    Stem Cell Reports; 2015 Dec; 5(6):1053-1066. PubMed ID: 26549847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency.
    Garcia-Gomez M; Calabria A; Garcia-Bravo M; Benedicenti F; Kosinski P; López-Manzaneda S; Hill C; Del Mar Mañu-Pereira M; Martín MA; Orman I; Vives-Corrons JL; Kung C; Schambach A; Jin S; Bueren JA; Montini E; Navarro S; Segovia JC
    Mol Ther; 2016 Aug; 24(7):1187-98. PubMed ID: 27138040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TALEN mediated gene editing in a mouse model of Fanconi anemia.
    Pino-Barrio MJ; Giménez Y; Villanueva M; Hildenbeutel M; Sánchez-Dominguez R; Rodríguez-Perales S; Pujol R; Surrallés J; Río P; Cathomen T; Mussolino C; Bueren JA; Navarro S
    Sci Rep; 2020 Apr; 10(1):6997. PubMed ID: 32332829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome.
    Kuo CY; Long JD; Campo-Fernandez B; de Oliveira S; Cooper AR; Romero Z; Hoban MD; Joglekar AV; Lill GR; Kaufman ML; Fitz-Gibbon S; Wang X; Hollis RP; Kohn DB
    Cell Rep; 2018 May; 23(9):2606-2616. PubMed ID: 29847792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases.
    Renaud JB; Boix C; Charpentier M; De Cian A; Cochennec J; Duvernois-Berthet E; Perrouault L; Tesson L; Edouard J; Thinard R; Cherifi Y; Menoret S; Fontanière S; de Crozé N; Fraichard A; Sohm F; Anegon I; Concordet JP; Giovannangeli C
    Cell Rep; 2016 Mar; 14(9):2263-2272. PubMed ID: 26923600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-viral DNA delivery and TALEN editing correct the sickle cell mutation in hematopoietic stem cells.
    Moiani A; Letort G; Lizot S; Chalumeau A; Foray C; Felix T; Le Clerre D; Temburni-Blake S; Hong P; Leduc S; Pinard N; Marechal A; Seclen E; Boyne A; Mayer L; Hong R; Pulicani S; Galetto R; Gouble A; Cavazzana M; Juillerat A; Miccio A; Duclert A; Duchateau P; Valton J
    Nat Commun; 2024 Jun; 15(1):4965. PubMed ID: 38862518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
    Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
    Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Editing in Human Pluripotent Stem Cells.
    Carlson-Stevermer J; Saha K
    Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous recombination-mediated targeted integration in monkey embryos using TALE nucleases.
    Chu C; Yang Z; Yang J; Yan L; Si C; Kang Y; Chen Z; Chen Y; Ji W; Niu Y
    BMC Biotechnol; 2019 Jan; 19(1):7. PubMed ID: 30646876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted gene therapy into a safe harbor site in human hematopoietic progenitor cells.
    Rodriguez-Fornes F; Quintana-Bustamante O; Lozano ML; Segovia JC; Bueren JA; Guenechea G
    Gene Ther; 2020 Sep; 27(9):435-450. PubMed ID: 32218505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Bicistronic TALENs Greatly Improve Genome Editing.
    Martín-Fernández JM; Fleischer A; Vallejo-Diez S; Palomino E; Sánchez-Gilabert A; Ruiz R; Bejarano Y; Llinàs P; Gayá A; Bachiller D
    Curr Protoc Stem Cell Biol; 2020 Mar; 52(1):e104. PubMed ID: 32023363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Stable Knockout Mammalian Cells by TALEN-Mediated Locus-Specific Gene Editing.
    Mahata B; Biswas K
    Methods Mol Biol; 2017; 1498():107-120. PubMed ID: 27709571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TALEN-Mediated Mutagenesis and Genome Editing.
    Ma AC; Chen Y; Blackburn PR; Ekker SC
    Methods Mol Biol; 2016; 1451():17-30. PubMed ID: 27464798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A guide for drug inducible genome editing with HIT systems.
    Zhao C; Wei S; Wang Y
    Methods Enzymol; 2019; 621():53-68. PubMed ID: 31128789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish.
    Zhang Y; Huang H; Zhang B; Lin S
    Methods Cell Biol; 2016; 135():107-20. PubMed ID: 27443922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage.
    Seclen E; Jang JC; Lawal AO; Pulicani S; Boyne A; Tkach D; Juillerat A; Duchateau P; Valton J
    Mol Ther; 2024 Jun; 32(6):1643-1657. PubMed ID: 38582963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific correction of pyruvate kinase deficiency-causing point mutations by CRISPR/Cas9 and single-stranded oligodeoxynucleotides.
    Fañanas-Baquero S; Morín M; Fernández S; Ojeda-Perez I; Dessy-Rodriguez M; Giurgiu M; Bueren JA; Moreno-Pelayo MA; Segovia JC; Quintana-Bustamante O
    Front Genome Ed; 2023; 5():1104666. PubMed ID: 37188156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.